Literature DB >> 25743215

Recent advances of chroman-4-one derivatives: synthetic approaches and bioactivities.

Saeed Emami1, Zahra Ghanbarimasir2.   

Abstract

Chroman-4-one scaffold is a privileged structure in heterocyclic chemistry and drug discovery. Also, chroman-4-ones are important intermediates and interesting building blocks in organic synthesis and drug design. The structural diversity found in the chroman-4-one family led to their division into several categories including benzylidene-4-chromanones, flavanones (2-phenyl-4-chromanones), isoflavanones (3-phenyl-4-chromanones), spirochromanones, and C-4 modified chroman-4-ones such as hydrazones and oxime derivatives. This review addresses the most significant synthetic methods reported on 4-chromanone-derived compounds and consequently emphasizes on the biological relevance of such compounds.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  2,3-Dihydro-1-benzopyran-4-one; Biological activity; Chroman-4-one; Flavanone; Isoflavanone

Mesh:

Substances:

Year:  2015        PMID: 25743215     DOI: 10.1016/j.ejmech.2015.02.048

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Synthesis, computational study and cytotoxicity of 4-hydroxycoumarin-derived imines/enamines.

Authors:  Samaneh Vaseghi; Mohammad Yousefi; Mohammad Shokrzadeh; Zinatossadat Hossaini; Zahra Hosseini-Khah; Saeed Emami
Journal:  Mol Divers       Date:  2020-04-22       Impact factor: 2.943

2.  Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology.

Authors:  John M Ketcham; Ivan Volchkov; Te-Yu Chen; Peter M Blumberg; Noemi Kedei; Nancy E Lewin; Michael J Krische
Journal:  J Am Chem Soc       Date:  2016-09-27       Impact factor: 15.419

3.  Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity.

Authors:  Myunghoe Heo; Bit Lee; Kamakshi Sishtla; Xiang Fei; Sanha Lee; Soojun Park; Yue Yuan; Seul Lee; Sangil Kwon; Jungeun Lee; Sanghee Kim; Timothy W Corson; Seung-Yong Seo
Journal:  J Org Chem       Date:  2019-08-05       Impact factor: 4.354

4.  Hydrazone Derivatives Enhance Antileishmanial Activity of Thiochroman-4-ones.

Authors:  Esteban Vargas; Fernando Echeverri; Yulieth A Upegui; Sara M Robledo; Wiston Quiñones
Journal:  Molecules       Date:  2017-12-29       Impact factor: 4.411

5.  Crystal structures of (E)-3-(4-hy-droxy-benzyl-idene)chroman-4-one and (E)-3-(3-hy-droxy-benzyl-idene)-2-phenyl-chroman-4-one.

Authors:  Kamil Suchojad; Anna Dołęga; Angelika Adamus-Grabicka; Elżbieta Budzisz; Magdalena Małecka
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-11-22

6.  New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies.

Authors:  Elena Pini; Giulio Poli; Tiziano Tuccinardi; Laurent Roberto Chiarelli; Matteo Mori; Arianna Gelain; Luca Costantino; Stefania Villa; Fiorella Meneghetti; Daniela Barlocco
Journal:  Molecules       Date:  2018-06-21       Impact factor: 4.411

7.  Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.

Authors:  Yuheng Hu; Bing Wang; Jie Yang; Teng Liu; Jie Sun; Xiaojing Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

8.  In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme.

Authors:  Nayim Sepay; Nadir Sepay; Ashique Al Hoque; Rina Mondal; Umesh Chandra Halder; Mohd Muddassir
Journal:  Struct Chem       Date:  2020-05-13       Impact factor: 1.887

Review 9.  Chromanone-A Prerogative Therapeutic Scaffold: An Overview.

Authors:  Sonia Kamboj; Randhir Singh
Journal:  Arab J Sci Eng       Date:  2021-06-30       Impact factor: 2.807

10.  New chroman-4-one/thiochroman-4-one derivatives as potential anticancer agents.

Authors:  Seref Demirayak; Leyla Yurttas; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
Journal:  Saudi Pharm J       Date:  2017-04-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.